C07K 2319/03
Containing a transmembrane segment
Official title: containing a transmembrane segment
C07K2319/03 (Containing a transmembrane segment) appears on 2,591 US grants and 6,172 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,591
- Published applications
- 6,172
- Assignees
- 1,673
- Inventors
- 8,970
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 12 | 0 |
| 2000 | 13 | 0 |
| 2001 | 4 | 0 |
| 2002 | 8 | 5 |
| 2003 | 5 | 14 |
| 2004 | 1 | 11 |
| 2005 | 3 | 10 |
| 2006 | 3 | 20 |
| 2007 | 5 | 12 |
| 2008 | 8 | 14 |
| 2009 | 5 | 20 |
| 2010 | 11 | 25 |
| 2011 | 11 | 29 |
| 2012 | 13 | 26 |
| 2013 | 13 | 44 |
| 2014 | 15 | 47 |
| 2015 | 27 | 62 |
| 2016 | 51 | 116 |
| 2017 | 61 | 214 |
| 2018 | 74 | 301 |
| 2019 | 130 | 429 |
| 2020 | 223 | 562 |
| 2021 | 243 | 719 |
| 2022 | 297 | 784 |
| 2023 | 289 | 718 |
| 2024 | 370 | 841 |
| 2025 | 408 | 681 |
| 2026 | 277 | 468 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bispecific chimeric antigen receptors targeting CD20 and BCMA6 Oct 2026US 12,751,973 B2Abelzeta Inc.
- Dual CAR expressing T cells individually linked to CD28 and 4-1BB6 Oct 2026US 12,753,218 B2The Trustees of the University of Pennsylvania
- Mesothelin specific chimeric antigen receptors (CAR) for solid tumors cancer immunotherapy6 Oct 2026US 12,753,220 B2Cellectis
- Anti-Nectin-4 antibody, conjugate including the same, and application thereof6 Oct 2026US 12,753,230 B2Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- CD5 chimeric antigen receptor for adoptive T cell therapy29 Sep 2026US 12,746,273 B2Baylor College of Medicine
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Prefusion-stabilized human parainfluenza virus 3 f proteins8 Oct 2026US 2026/0306613 A1Board of Regents, The University of Texas System
- Chimeric receptors8 Oct 2026US 2026/0306631 A1St. Jude Children?S Research Hospital
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
- Chimeric engulfment receptor molecules and methods of use8 Oct 2026US 2026/0308281 A1Cero Therapeutics Holdings, Inc.
Most cited
By later US patents
- Methods for treatment of cancer368US 8,906,682 B2The Trustees of the University of Pennsylvania · 2014
- Chimeric receptor genes and cells transformed therewith327US 7,741,465 B12010
- Compositions for treatment of cancer277US 8,911,993 B2The Trustees of the University of Pennsylvania · 2014
- CE7-specific redirected immune cells263US 7,070,995 B2City of Hope · 2006
- Methods for treatment of cancer216US 8,916,381 B1The Trustees of the University of Pennyslvania · 2014